Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04704323
Title CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Catapult Therapeutics
Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.